Fig. 2From: Clinical inertia on insulin treatment intensification in type 2 diabetes mellitus patients of a tertiary public diabetes center with limited pharmacologic armamentarium from an upper-middle income countryHbA1c, insulin daily dose and clinical inertia prevalence in Group 1 (323 Type 2 diabetes mellitus patients) during 2 years of follow upBack to article page